LOS ALTOS, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) today announced the initiation of a Phase 2 double-blind, placebo-controlled study of its transdermal formulation of ...
Researchers at The University of Osaka have developed and evaluated a new eight-week training program that enables psychology trainees to effectively learn cognitive behavioral therapy (CBT) by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results